1 |
刘国信. 猪伪狂犬病、猪圆环病毒病与猪弓形体病混合感染的诊治[J]. 云南农业科技, 2019, (5): 57- 58.
doi: 10.3969/j.issn.1000-0488.2019.05.023
|
|
LIU G X . Integrated diagnosis of mixed infection for swine PRV, PCV-2 and toxoplasmosis[J]. Yunnan Agricultural Science and Technology, 2019, (5): 57- 58.
doi: 10.3969/j.issn.1000-0488.2019.05.023
|
2 |
ZHENG H H , FU P F , CHEN H Y , et al. Pseudorabies virus: from pathogenesis to prevention strategies[J]. Viruses, 2022, 14 (8): 1638.
doi: 10.3390/v14081638
|
3 |
POMERANZ L E , REYNOLDS A E , HENGARTNER C J . Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine[J]. Microbiol Mol Biol Rev, 2005, 69 (3): 462- 500.
doi: 10.1128/MMBR.69.3.462-500.2005
|
4 |
LIN J X , LI Z L , FENG Z H , et al. Pseudorabies virus (PRV) strain with defects in gE, gC, and TK genes protects piglets against an emerging PRV variant[J]. J Vet Med Sci, 2020, 82 (6): 846- 855.
doi: 10.1292/jvms.20-0176
|
5 |
KIM H H , JI M , WANG J Y , et al. The presence of antibodies against pseudorabies virus in wild boars (sus scrofa) in Korea[J]. J Zoo Wildl Med, 2021, 51 (4): 981- 984.
|
6 |
黄武光, 仇华吉. 猪伪狂犬病临床诊断要点[J]. 动物科学与动物医学, 2005, 22 (6): 36.
doi: 10.3969/j.issn.1673-5358.2005.06.015
|
|
HUANG W G , QIU H J . Key points for clinical diagnosis of porcine pseudorabies[J]. Animal Science & Veterinary Medicine, 2005, 22 (6): 36.
doi: 10.3969/j.issn.1673-5358.2005.06.015
|
7 |
TAN L , YAO J , YANG Y D , et al. Current status and challenge of pseudorabies virus infection in China[J]. Virol Sin, 2021, 36 (4): 588- 607.
doi: 10.1007/s12250-020-00340-0
|
8 |
OU J J , CAI S Q , ZHENG F Y , et al. Human pseudorabies virus infection: a new threat in China[J]. J Infect, 2020, 80 (5): 578- 606.
|
9 |
杨旭宇. TSG101基因研究进展[J]. 国外医学分子生物学分册, 2003, 25 (2): 65- 67.
doi: 10.3870/j.issn.1672-8009.2003.02.001
|
|
YANG X Y . Progress in TSG101 gene research[J]. Foreign Medicine (Molecular Biology Volume), 2003, 25 (2): 65- 67.
doi: 10.3870/j.issn.1672-8009.2003.02.001
|
10 |
FERRAIUOLO R M , MANTHEY K C , STANTON M J , et al. The multifaceted roles of the tumor susceptibility gene 101 (TSG101) in normal development and disease[J]. Cancers (Basel), 2020, 12 (2): 450.
doi: 10.3390/cancers12020450
|
11 |
吕翔, 苏玉文. TSG101基因与肿瘤的研究进展[J]. 实用预防医学, 2008, 15 (3): 960- 962.
doi: 10.3969/j.issn.1006-3110.2008.03.159
|
|
LV X , SU Y W . Research progress on TSG101 gene and tumors[J]. Practical Preventive Medicine, 2008, 15 (3): 960- 962.
doi: 10.3969/j.issn.1006-3110.2008.03.159
|
12 |
陈洪飞, 刘新泳. TSG101蛋白在HIV-1出芽过程中的作用及其抑制剂[J]. 药学学报, 2008, 43 (12): 1165- 1170.
doi: 10.3321/j.issn:0513-4870.2008.12.001
|
|
CHEN H F , LIU X Y . The action of TSG101 on HIV-1 budding and related inhibitors[J]. Acta Pharmaceutica Sinica, 2008, 43 (12): 1165- 1170.
doi: 10.3321/j.issn:0513-4870.2008.12.001
|
13 |
GARRUS J E , VON SCHWEDLER U K , PORNILLOS O W , et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding[J]. Cell, 2001, 107 (1): 55- 65.
doi: 10.1016/S0092-8674(01)00506-2
|
14 |
许岩, 张莹. TSG101在病毒出芽过程中的作用及其机制[J]. 微生物学杂志, 2015, 35 (6): 90- 95.
|
|
XU Y , ZHANG Y . The action and mechanism of TSG101 during virus budding[J]. Journal of Microbiology, 2015, 35 (6): 90- 95.
|
15 |
霍云飞, 寇卜心, 柴梦音, 等. 体外靶向TP53BP2基因shRNA慢病毒载体的构建及功能鉴定[J]. 实用肝脏病杂志, 2023, 26 (2): 164- 168.
|
|
HUO Y F , KOU B X , CHAI M Y , et al. Construction and functional verification of a shRNA lentiviral vector targeting to TP53BP2 gene in HepG2 cells in vitro[J]. Journal of Practical Hepatology, 2023, 26 (2): 164- 168.
|
16 |
李秋燕, 王睿敏, 曾金坛, 等. 猪伪狂犬病的防控策略及净化方案[J]. 畜禽业, 2023, 34 (9): 43- 45.
|
|
LI Q Y , WANG R M , ZENG J T , et al. Prevention and control strategies and purification plans for porcine pseudorabies[J]. Livestock and Poultry Industry, 2023, 34 (9): 43- 45.
|
17 |
SEHL J , TEIFKE J P . Comparative pathology of pseudorabies in different naturally and experimentally infected species-a review[J]. Pathogens, 2020, 9 (8): 633.
doi: 10.3390/pathogens9080633
|
18 |
孙廷艳. 猪伪狂犬病的流行趋势及防控[J]. 国外畜牧学(猪与禽), 2023, 43 (4): 65- 67.
|
|
SUN T Y . The epidemic trends and prevention and control of pseudorabies in pigs[J]. Animal Science Abroad-Pigs and Poultry, 2023, 43 (4): 65- 67.
|
19 |
XIE J Y , LI X R , YANG S Y , et al. DDX56 inhibits PRV replication through regulation of IFN-β signaling pathway by targeting cGAS[J]. Front Microbiol, 2022, 13, 932842.
|
20 |
LI X R , XIE J Y , LI D Y , et al. HSP27 attenuates cGAS-mediated IFN-β signaling through ubiquitination of cGAS and promotes PRV infection[J]. Viruses, 2022, 14 (9): 1851.
|
21 |
XU W Y , YAN P , ZHOU Z Y , et al. HDAC6 triggers the ATM-dependent DNA damage response to promote PRV replication[J]. Microbiol Spectr, 2023, 11 (2): e0213222.
|
22 |
李朝飞, 田宏刚, 刘同先. 内吞体分选转运复合体(ESCRT)及其在包膜病毒出芽中的作用[J]. 生物工程学报, 2012, 28 (9): 1031- 1037.
|
|
LI Z F , TIAN H G , LIU T X . Cellular ESCRT complex and its roles in enveloped viruses budding[J]. Chinese Journal of Biotechnology, 2012, 28 (9): 1031- 1037.
|
23 |
LUYET P P , FALGUIÈRES T , PONS V , et al. The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of viral RNA[J]. Traffic, 2008, 9 (12): 2279- 2290.
|
24 |
ZHANG L X , LI R , GENG R , et al. Tumor susceptibility gene 101 (TSG101) contributes to virion formation of porcine reproductive and respiratory syndrome virus via interaction with the nucleocapsid (N) protein along with the early secretory pathway[J]. J Virol, 2022, 96 (6): e0000522.
|
25 |
MANNEMUDDHU S S , XU H Z , BLECK C K E , et al. Prazoles targeting tsg101 inhibit release of epstein-barr virus following reactivation from latency[J]. J Virol, 2021, 95 (13): e0246620.
|
26 |
LEIS J , LUAN C H , AUDIA J E , et al. Ilaprazole and other novel prazole-based compounds that bind tsg101 inhibit viral budding of herpes simplex virus 1 and 2 and human immunodeficiency virus from cells[J]. J Virol, 2021, 95 (11): e00190- 21.
|
27 |
STRICKLAND M , EHRLICH L S , WATANABE S , et al. Tsg101 chaperone function revealed by HIV-1 assembly inhibitors[J]. Nat Commun, 2017, 8 (1): 1391.
|
28 |
KUMAR B , DUTTA D , IQBAL J , et al. ESCRT-I protein tsg101 plays a role in the post-macropinocytic trafficking and infection of endothelial cells by Kaposi's sarcoma-associated herpesvirus[J]. PLoS Pathog, 2016, 12 (10): e1005960.
|